US govt seeks new trial in Gilead HIV drug patent case

18-05-2023

Muireann Bolger

US govt seeks new trial in Gilead HIV drug patent case

shutterstock_1569359980_Sundry Photography

The government lost its high stakes and unusual royalties dispute with the big pharma firm | New status report claims that the court should have allowed the jury to take four inter partes petitions into account.


Gilead, HIV, Truvada, Descovy, PrEP, patents, inter partes petitions, pharma, US government

LSIPR